We serve Chemical Name:4-Amino-6-bromopyrimidine CAS:1159818-57-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Amino-6-bromopyrimidine
CAS.NO:1159818-57-1
Synonyms:6-Bromo-4-pyrimidinamine;4-pyrimidinamine, 6-bromo-;4-Bromo-6-aminopyrimidine;6-BROMO-PYRIMIDINE-4-YLAMINE;6-BROMO-PYRIMIDIN-4-YLAMINE;6-BROMO-4-AMINOPYRIMIDINE;6-Bromopyrimidin-4-amine;4-Amino-6-bromopyrimidine
Molecular Formula:C4H4BrN3
Molecular Weight:173.999
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:303.2±22.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.649
PSA:51.80000
Exact Mass:172.958847
LogP:1.12
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-Bromo-4-pyrimidinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Amino-6-bromopyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-6-aminopyrimidine Use and application,6-BROMO-PYRIMIDIN-4-YLAMINE technical grade,usp/ep/jp grade.
Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 4-Amino-6-bromopyrimidine manufacturer APIs are generally manufactured through a variety of processes that include. 4-Amino-6-bromopyrimidine supplier The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). 4-Amino-6-bromopyrimidine vendor ��We are very worried,�� Chuang Shuk-kwan, a health official, said at a news conference on Sunday. ��Everyone should prepare mentally for the possibility that the disease is spreading within the community.�� 4-Amino-6-bromopyrimidine factory APIs are generally manufactured through a variety of processes that include.
